levofloxacin has been researched along with erlotinib hydrochloride in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 4,353 | 786 | 3,033 |
| Protein | Taxonomy | levofloxacin (IC50) | erlotinib hydrochloride (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.1683 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 1.705 | |
| Serine/threonine-protein kinase B-raf | Mus musculus (house mouse) | 0.04 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guglieri-López, B; Merino, V; Merino-Sanjuan, M; Nacher, A; Pérez-Pitarch, A | 1 |
1 other study(ies) available for levofloxacin and erlotinib hydrochloride
| Article | Year |
|---|---|
Levofloxacin effect on erlotinib absorption. Evaluation of the interaction in undernutrition situations through population pharmacokinetic analysis in rats.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Drug Interactions; Erlotinib Hydrochloride; Intestinal Absorption; Intestinal Mucosa; Levofloxacin; Male; Malnutrition; Models, Biological; Protein Kinase Inhibitors; Rats, Wistar; Serum Albumin | 2017 |